Trial intelligence / Profile preview

Phase II/III Study of subcutaneous DNK-FLU in Healthy Japanese Children

jRCT2080221243Phase 3

Sponsor
Denka
Start
Sep 2010
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, single-arm trial of DNK-FLU in influenza, sponsored by Denka.

02

Drugs

DNK-FLU
03

Conditions

influenza

Beyond the preview

Go deeper on jRCT2080221243.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221243.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call